A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.

[1]  S. Spijkers,et al.  A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism. , 2010, The Journal of antimicrobial chemotherapy.

[2]  M. Nussenzweig,et al.  Human anti–HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness , 2010, The Journal of experimental medicine.

[3]  Mario Roederer,et al.  Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.

[4]  J. Blankson,et al.  Seronegative HIV-1 infection: a review of the literature , 2010, AIDS.

[5]  J. Mascola,et al.  Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 , 2010, Journal of Virology.

[6]  J. Martinez-Picado,et al.  HIV and Mature Dendritic Cells: Trojan Exosomes Riding the Trojan Horse? , 2010, PLoS pathogens.

[7]  Q. Sattentau,et al.  SDF-1/CXCL12 Production by Mature Dendritic Cells Inhibits the Propagation of X4-Tropic HIV-1 Isolates at the Dendritic Cell-T-Cell Infectious Synapse , 2010, Journal of Virology.

[8]  John A. G. Briggs,et al.  Virological Synapse-Mediated Spread of Human Immunodeficiency Virus Type 1 between T Cells Is Sensitive to Entry Inhibition , 2010, Journal of Virology.

[9]  Q. Sattentau,et al.  Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals , 2010, PloS one.

[10]  Richard T. Wyatt,et al.  Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables , 2009, Journal of Virology.

[11]  B. Clotet,et al.  On the steps of cell-to-cell HIV transmission between CD4 T cells , 2009, Retrovirology.

[12]  Pham Phung,et al.  Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.

[13]  Nathan H. Roy,et al.  Formation of Syncytia Is Repressed by Tetraspanins in Human Immunodeficiency Virus Type 1-Producing Cells , 2009, Journal of Virology.

[14]  Q. Sattentau,et al.  International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II , 2009, PloS one.

[15]  B. Clotet,et al.  Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells , 2009, AIDS.

[16]  John R. Mascola,et al.  Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals , 2008, Journal of Virology.

[17]  D. Dimitrov,et al.  Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers , 2008, Proceedings of the National Academy of Sciences.

[18]  Lynn Morris,et al.  Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C , 2008, Journal of Virology.

[19]  E. Ruggiero,et al.  Virological Consequences of Early Events following Cell-Cell Contact between Human Immunodeficiency Virus Type 1-Infected and Uninfected CD4+ Cells , 2008, Journal of Virology.

[20]  M. Juan,et al.  HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4 , 2008, Retrovirology.

[21]  Mark Connors,et al.  Broad HIV-1 neutralization mediated by CD4-binding site antibodies , 2007, Nature Medicine.

[22]  W. Hübner,et al.  Predominant Mode of Human Immunodeficiency Virus Transfer between T Cells Is Mediated by Sustained Env-Dependent Neutralization-Resistant Virological Synapses , 2007, Journal of Virology.

[23]  Douglas D. Richman,et al.  Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors , 2007, Journal of Virology.

[24]  J. Alcamí,et al.  A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1 , 2007, Journal of medical virology.

[25]  Ruchi M. Newman,et al.  Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α , 2006, Proceedings of the National Academy of Sciences.

[26]  F. Mitjans,et al.  Inhibition of human immunodeficiency virus type 1 infection in macrophages by an alpha-v integrin blocking antibody. , 2006, Antiviral research.

[27]  B. Clotet,et al.  Inhibition of Coreceptor-Independent Cell-to-Cell Human Immunodeficiency Virus Type 1 Transmission by a CD4-Immunoglobulin G2 Fusion Protein , 2005, Antimicrobial Agents and Chemotherapy.

[28]  B. Clotet,et al.  Multiparametric Assay To Screen and Dissect the Mode of Action of Anti-Human Immunodeficiency Virus Envelope Drugs , 2005, Antimicrobial Agents and Chemotherapy.

[29]  J. Barretina,et al.  High Level of Coreceptor-independent HIV Transfer Induced by Contacts between Primary CD4 T Cells* , 2004, Journal of Biological Chemistry.

[30]  J. Barretina,et al.  R5 HIV gp120‐mediated cellular contacts induce the death of single CCR5‐expressing CD4 T cells by a gp41‐dependent mechanism , 2004, Journal of leukocyte biology.

[31]  Q. Sattentau,et al.  Dangerous liaisons at the virological synapse. , 2004, The Journal of clinical investigation.

[32]  J. Mascola,et al.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.

[33]  K. Salzwedel,et al.  Sequential CD4-Coreceptor Interactions in Human Immunodeficiency Virus Type 1 Env Function: Soluble CD4 Activates Env for Coreceptor-Dependent Fusion and Reveals Blocking Activities of Antibodies against Cryptic Conserved Epitopes on gp120 , 2000, Journal of Virology.

[34]  J. Blanco,et al.  Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells , 1997, Journal of virology.

[35]  Q. Sattentau,et al.  Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization , 1997, The Journal of experimental medicine.

[36]  A. Trkola,et al.  Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex , 1997, Journal of virology.

[37]  J. Mallol,et al.  Characterization of adenosine receptors in brush‐border membranes from pig kidney , 1992, British journal of pharmacology.